Terms: = Breast cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Prognosis
21 results:
1. Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian breast cancer Patients.
Ibrahim NE; Raafat Hamed RM; Refaat A; Mosaad YO; Mekawy DM
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3517-3523. PubMed ID: 37898858
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and prognostic role of sarcopenia based on masticatory muscle index on MR images in patients with extranodal natural killer/T cell lymphoma, nasal type.
Xu T; Li Y; Liu Y; Ning B; Wu H; Wei Y
Ann Hematol; 2023 Dec; 102(12):3521-3532. PubMed ID: 37702822
[TBL] [Abstract] [Full Text] [Related]
3. Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy.
Lee JW; Oh H; You JY; Lee ES; Lee JH; Song SE; Lee NK; Jung SP; An JS; Cho KR; Kim CY; Park KH
Eur J Cancer; 2023 Sep; 191():112952. PubMed ID: 37473463
[TBL] [Abstract] [Full Text] [Related]
4. Long-Term Risk of Being Bedridden in Elderly Patients Who Underwent Oncologic Surgery: A Retrospective Study Using a Japanese Claims Database.
Konishi T; Sasabuchi Y; Matsui H; Tanabe M; Seto Y; Yasunaga H
Ann Surg Oncol; 2023 Aug; 30(8):4604-4612. PubMed ID: 37149549
[TBL] [Abstract] [Full Text] [Related]
5. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract] [Full Text] [Related]
6. Limited resection for stage IA radiologically invasive lung cancer: a real-world nationwide database study.
Soh J; Toyooka S; Shintani Y; Okami J; Ito H; Ohtsuka T; Mori T; Watanabe SI; Asamura H; Chida M; Endo S; Nakanishi R; Kadokura M; Suzuki H; Miyaoka E; Yoshino I; Date H;
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35678584
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis.
Xu H; Liu Z; Shi H; Wang C
BMC Cancer; 2020 Nov; 20(1):1051. PubMed ID: 33131491
[TBL] [Abstract] [Full Text] [Related]
8. The effect of postoperative complications on survival and recurrence after surgery for breast cancer: A systematic review and meta-analysis.
Savioli F; Edwards J; McMillan D; Stallard S; Doughty J; Romics L
Crit Rev Oncol Hematol; 2020 Nov; 155():103075. PubMed ID: 32987333
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of imaging findings and prognostic factors after whole-brain radiotherapy for carcinomatous meningitis from breast cancer: A retrospective analysis.
Okada Y; Abe T; Shinozaki M; Tanaka A; Kobayashi M; Hiromichi G; Kanemaki Y; Nakamura N; Kojima Y
Medicine (Baltimore); 2020 Jul; 99(31):e21333. PubMed ID: 32756119
[TBL] [Abstract] [Full Text] [Related]
10. The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean breast cancer Society.
Kim HS; Yoo TK; Park WC; Chae BJ
Breast Cancer Res Treat; 2020 Apr; 180(2):461-470. PubMed ID: 32020434
[TBL] [Abstract] [Full Text] [Related]
11. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract] [Full Text] [Related]
12. Disease Severity, Presentation, and Clinical Outcomes Among Adolescents With Malignant breast Neoplasms: A 20-Year Population-Based Outcomes Study From the SEER Database (1973-2009).
Murthy V; Pawar S; Chamberlain RS
Clin Breast Cancer; 2017 Aug; 17(5):392-398. PubMed ID: 28602452
[TBL] [Abstract] [Full Text] [Related]
13. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
Bosukonda A; Carlson WD
Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
[TBL] [Abstract] [Full Text] [Related]
14. Expression and prognostic value of miR-92a in patients with gastric cancer.
Ren C; Wang W; Han C; Chen H; Fu D; Luo Y; Yao H; Wang D; Ma L; Zhou L; Han D; Shen M
Tumour Biol; 2016 Jul; 37(7):9483-91. PubMed ID: 26790436
[TBL] [Abstract] [Full Text] [Related]
15. breast cancer prognosis and isolated tumor cell findings in axillary lymph nodes after core needle biopsy and fine needle aspiration cytology: Biopsy method and breast cancer outcome.
Liikanen J; Leidenius M; Joensuu H; Vironen J; Heikkilä P; Meretoja T
Eur J Surg Oncol; 2016 Jan; 42(1):64-70. PubMed ID: 26427542
[TBL] [Abstract] [Full Text] [Related]
16. Randomized, phase II, placebo-controlled trial of onartuzumab and/or bevacizumab in combination with weekly paclitaxel in patients with metastatic triple-negative breast cancer.
Diéras V; Campone M; Yardley DA; Romieu G; Valero V; Isakoff SJ; Koeppen H; Wilson TR; Xiao Y; Shames DS; Mocci S; Chen M; Schmid P
Ann Oncol; 2015 Sep; 26(9):1904-1910. PubMed ID: 26202594
[TBL] [Abstract] [Full Text] [Related]
17. Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women.
Redaniel MT; Jeffreys M; May MT; Ben-Shlomo Y; Martin RM
Cancer Causes Control; 2012 Nov; 23(11):1785-95. PubMed ID: 22971998
[TBL] [Abstract] [Full Text] [Related]
18. Non-sentinel lymph node status and prognosis of breast cancer patients with micrometastatic sentinel lymph nodes.
Onishi T; Jinno H; Takahashi M; Hayashida T; Sakata M; Nakahara T; Shigematsu N; Mukai M; Kitagawa Y
Eur Surg Res; 2010; 45(3-4):344-9. PubMed ID: 21088425
[TBL] [Abstract] [Full Text] [Related]
19. breast cancer among Hispanic and non-Hispanic White women in Arizona.
Martínez ME; Nielson CM; Nagle R; Lopez AM; Kim C; Thompson P
J Health Care Poor Underserved; 2007 Nov; 18(4 Suppl):130-45. PubMed ID: 18065856
[TBL] [Abstract] [Full Text] [Related]
20. Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.
Foekens JA; Schmitt M; van Putten WL; Peters HA; Kramer MD; Jänicke F; Klijn JG
J Clin Oncol; 1994 Aug; 12(8):1648-58. PubMed ID: 8040677
[TBL] [Abstract] [Full Text] [Related]
[Next]
